Cargando…
Impaired Humoral Response in Renal Transplant Recipients to SARS-CoV-2 Vaccination with BNT162b2 (Pfizer-BioNTech)
The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has a major impact on transplant recipients, with mortality rates up to 20%. Therefore, the effect of established messenger RNA (mRNA)-based SARS-CoV-2 vaccines have to be evaluated for solid organ transplant patients (SOT) since they...
Autores principales: | Korth, Johannes, Jahn, Michael, Dorsch, Oliver, Anastasiou, Olympia Evdoxia, Sorge-Hädicke, Burkhard, Eisenberger, Ute, Gäckler, Anja, Dittmer, Ulf, Witzke, Oliver, Wilde, Benjamin, Dolff, Sebastian, Kribben, Andreas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8146144/ https://www.ncbi.nlm.nih.gov/pubmed/33923063 http://dx.doi.org/10.3390/v13050756 |
Ejemplares similares
-
Humoral Response to SARS-CoV-2-Vaccination with BNT162b2 (Pfizer-BioNTech) in Patients on Hemodialysis
por: Jahn, Michael, et al.
Publicado: (2021) -
Decline of Humoral Responses 6 Months after Vaccination with BNT162b2 (Pfizer–BioNTech) in Patients on Hemodialysis
por: Jahn, Michael, et al.
Publicado: (2022) -
Evidence of cell-mediated immune response in kidney transplants with a negative mRNA vaccine antibody response
por: Dolff, Sebastian, et al.
Publicado: (2021) -
A racing heart post‐Pfizer/BioNTech BNT162b2
por: Teo, Hooi Khee, et al.
Publicado: (2022) -
Randomized, open-label, comparative phase IV study on the bioavailability of Ciclosporin Pro (Teva) versus Sandimmun® Optoral (Novartis) under fasting versus fed conditions in patients with stable renal transplants
por: Gäckler, Anja, et al.
Publicado: (2019)